The design and rationale for the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban (APEX) study

American Heart Journal

Volumn 167, Issue 3, 2014, Pages 335-341

  Cohen, Alexander T ^a   Harrington, Robert ^b   Goldhaber, Samuel Z ^c   Hull, Russell ^d   Gibson, C Michael ^c   Hernandez, Adrian F ^e   Kitt, Michael M ^f,g   Lorenz, Todd J ^g  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

^e DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^f MERCK RESEARCH LABORATORIES   (United States)

^g Portola Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETRIXABAN; ENOXAPARIN; PLACEBO;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; HUMAN; LUNG EMBOLISM; MIDDLE AGED; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BENZAMIDES; DOUBLE-BLIND METHOD; ENOXAPARIN; FACTOR XA; HUMANS; INTERNATIONALITY; MIDDLE AGED; PROSPECTIVE STUDIES; PYRIDINES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 84896734906     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.11.006     Document Type: Article

References (15)

1. A.N. Amin, H. Varker, and N. Princic et al. Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patients J Hosp Med 7 2012 231 238
2. M. Samama, A.T. Cohen, and J.Y. Darmon et al. Comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients N Engl J Med 341 11 1999 793 800
3. A. Leizorovicz, A.T. Cohen, and A.G.G. Turpie et al. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients Circulation 110 2004 874 879
4. A.T. Cohen, B.L. Davidson, and A.S. Gallus et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomized placebo controlled trial Br Med J 332 2006 325 329
5. J.A. Heit, J.M. Melton, and C.M. Lohse et al. Incidence of venous thromboembolism in hospitalized patients vs. community residents Mayo Clin Proc 76 2001 1102 1110
6. A.T. Cohen Results from the VEG Registry Results from the VEG Registry. International Society of Thrombosis and Haemostasis Meeting, Kyoto Japan 2011
7. R. Hull, S.M. Schellong, and V.F. Tapson et al. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility Ann Intern Med 153 2010 8 18
8. S. Schulman, and C. Kearon Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J Thromb Hemost 3 2005 692 694
9. A.T. Cohen, T.E. Spiro, and H.R. Buller et al. Rivaroxaban for thromboprophylaxis in acutely ill medical patients N Engl J Med 368 2013 513 523
10. S.Z. Goldhaber, A. Leizorovicz, and A.K. Kakkar et al. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients N Engl J Med 365 2011 2167 2177
11. S. Connolly, J. Eikelboom, and P. Dorian et al. Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (EXPLORE-Xa) Eur Heart J 34 20 2013 1498 1505
12. A. Turpie, K.A. Bauer, and B.L. Davidson et al. A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT) Thromb Haemost 101 2009 68 76
13. R.D. Hull, T. Mareli, and A. Mills et al. LiangJ. Venous thromboembolism in elderly high-risk medical patients: time course of events and influence of risk factors Clin Appl Thromb Hemost 19 4 2013 357 362
14. A.T. Cohen Results of subgroup analysis from the MAGELLAN Study International Society of Thrombosis and Haemostasis Meeting, Kyoto Japan 2011
15. S.R. Kahn, W. Lim, and A.S. Dunn et al. Prevention of VTE in nonsurgical patients Chest 141 2 Suppl 2012 195 226